Table 3.
Crude and adjusted hazard ratios for end-stage renal disease
| Variable |
Crude |
Adjusted1 |
||||
| HR | 95%CI | P value | HR | 95%CI | P value | |
| CKD patients | ||||||
| Uninfected | 1.00 | Reference | 1.00 | Reference | ||
| Treated | 0.31 | 0.13-0.77 | 0.011 | 0.34 | 0.14-0.84 | 0.019 |
| Untreated | 1.25 | 1.00-1.56 | 0.046 | 1.28 | 1.03-1.60 | 0.029 |
| Sex, men/women | 1.11 | 0.89-1.38 | 0.35 | 1.23 | 0.99-1.55 | 0.07 |
| Age, per year | 1.01 | 1.00-1.01 | 0.15 | 0.99 | 0.98-0.99 | 0.006 |
| Comorbidity, yes/no | ||||||
| Diabetes | 2.87 | 2.28-3.61 | < 0.001 | 3.06 | 2.37-3.95 | < 0.001 |
| Hypertension | 3.08 | 2.37-4.01 | < 0.001 | 3.51 | 2.57-4.79 | < 0.001 |
| Coronary heart disease | 1.28 | 1.02-1.59 | 0.031 | 0.92 | 0.72-1.16 | 0.46 |
| Hyperlipidemia | 1.29 | 1.04-1.60 | 0.023 | 0.85 | 0.68-1.07 | 0.16 |
| Cirrhosis | 0.62 | 0.46-0.83 | 0.001 | 0.61 | 0.44-0.84 | 0.003 |
| ACEI/ARB, yes/no | 1.38 | 0.65-2.92 | 0.40 | 0.96 | 0.46-2.04 | 0.92 |
| Enrollee category | ||||||
| 1 | 1.00 | Reference | 1.00 | Reference | ||
| 2 | 0.68 | 0.21-2.14) | 0.50 | 0.56 | 0.17-1.80 | 0.33 |
| 3 | 1.26 | 0.97-1.64 | 0.08 | 1.24 | 0.95-1.63 | 0.11 |
| 4 | 1.47 | 1.09-1.99 | 0.012 | 1.40 | 1.03-1.92 | 0.03 |
| Number of medical visits | 1.00 | 1.00-1.01 | 0.36 | 1.00 | 0.99-1.00 | 0.41 |
| Charlson comorbidity index score | 1.01 | 00.98-1.04 | 0.46 | 0.93 | 0.89-0.98 | 0.008 |
1
Adjusted for all covariates (age per year, sex, comorbidity, ACEI/ARB, enrollee category, number of medical visits, and Charlson comorbidity index score) and competing mortality. CKD: Chronic kidney disease; ACEI/ARB: Angiotensin converting enzyme inhibitor/angiotensin receptor blocker; CI: Confidence interval.